Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim relate...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-05-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | http://www.efsa.europa.eu/en/efsajournal/doc/3656.pdf |
_version_ | 1818728097974845440 |
---|---|
author | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
author_facet | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
author_sort | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
collection | DOAJ |
description | Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract. The food that is the subject of the claim is Pacran®. The Panel considers that the food, Pacran®, which is the subject of the claim is sufficiently characterised in relation to the claimed effect. The Panel considers that defence against bacterial pathogens in the lower urinary tract is a beneficial physiological effect. One human study from which conclusions could be drawn for the scientific substantiation of the claim showed no effect of Pacran® on defence against bacterial pathogens in the lower urinary tract. The Panel concludes that a cause and effect relationship has not been established between the consumption of Pacran® and defence against bacterial pathogens in the lower urinary tract. |
first_indexed | 2024-12-17T22:24:35Z |
format | Article |
id | doaj.art-8bc2a9938bff45669c6fffefe4508472 |
institution | Directory Open Access Journal |
issn | 1831-4732 |
language | English |
last_indexed | 2024-12-17T22:24:35Z |
publishDate | 2014-05-01 |
publisher | Wiley |
record_format | Article |
series | EFSA Journal |
spelling | doaj.art-8bc2a9938bff45669c6fffefe45084722022-12-21T21:30:23ZengWileyEFSA Journal1831-47322014-05-0112510.2903/j.efsa.2014.3656EFSA Journal 2014;12(5):3656Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Following an application from Naturex SA, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract. The food that is the subject of the claim is Pacran®. The Panel considers that the food, Pacran®, which is the subject of the claim is sufficiently characterised in relation to the claimed effect. The Panel considers that defence against bacterial pathogens in the lower urinary tract is a beneficial physiological effect. One human study from which conclusions could be drawn for the scientific substantiation of the claim showed no effect of Pacran® on defence against bacterial pathogens in the lower urinary tract. The Panel concludes that a cause and effect relationship has not been established between the consumption of Pacran® and defence against bacterial pathogens in the lower urinary tract.http://www.efsa.europa.eu/en/efsajournal/doc/3656.pdfPacran®proanthocyanidinscranberryVaccinium macrocarponurinary tracthealth claims |
spellingShingle | EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006 EFSA Journal Pacran® proanthocyanidins cranberry Vaccinium macrocarpon urinary tract health claims |
title | Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_full | Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_fullStr | Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_full_unstemmed | Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_short | Scientific Opinion on the substantiation of a health claim related to Pacran® and defence against bacterial pathogens in the lower urinary tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
title_sort | scientific opinion on the substantiation of a health claim related to pacran r and defence against bacterial pathogens in the lower urinary tract pursuant to article 13 5 of regulation ec no 1924 2006 |
topic | Pacran® proanthocyanidins cranberry Vaccinium macrocarpon urinary tract health claims |
url | http://www.efsa.europa.eu/en/efsajournal/doc/3656.pdf |
work_keys_str_mv | AT efsapanelondieteticproductsnutritionandallergiesnda scientificopiniononthesubstantiationofahealthclaimrelatedtopacrananddefenceagainstbacterialpathogensinthelowerurinarytractpursuanttoarticle135ofregulationecno19242006 |